AngioDynamics ANGO

Jump To Section

    $

    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    .
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    -$0.31 (-3.29%)Past DayToday's Volume:
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    ,
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0

    Relative Strength Index (RSI)

    - The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

    - The RSI is calculated using the following formula:

    RSI = 100 - (100 / (1 + RS))

    Where RS is the ratio of the average gains to the average losses over a specified period.

    - The default time period used is 14 days.

    - RSI values range between 0 and 100.

    RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

    RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

    RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

    About

    Business overview of AngioDynamics (ANGO)
    AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.

    Key Insights

    Critical company metrics and information
    • Latest Closing Price

      $9.1
    • Market Cap

      $368.24 Million
    • Price-Earnings Ratio

      -1.63
    • Total Outstanding Shares

      40.63 Million Shares
    • Total Employees

      748
    • Dividend

      No dividend
    • IPO Date

      May 27, 2004
    • SIC Description

      Surgical & Medical Instruments & Apparatus
    • Primary Exchange

      NASDAQ
    • Type

      Common Stock
    • Headquarters

      14 plaza drive, Latham, NY, 12110
    • Homepage

      https://www.angiodynamics.com

    Historical Stock Splits

    Execution DateSplit Amount
    No Historical Stock Splits

    Cash Flow Statement

    December 1, 2023 to November 30, 2024
    MetricValue
    Net Cash Flow From Financing Activities$-5.94 Million
    Net Cash Flow From Operating Activities$-23.30 Million
    Net Cash Flow From Investing Activities$22.70 Million
    Exchange Gains/Losses$-266,000
    Net Cash Flow From Operating Activities, Continuing$-23.30 Million
    Net Cash Flow From Investing Activities, Continuing$22.70 Million

    Income Statement

    December 1, 2023 to November 30, 2024
    MetricValue
    Operating Income/Loss$-238.54 Million
    Basic Earnings Per Share$-5.57
    Income/Loss From Continuing Operations After Tax$-224.72 Million
    Net Income/Loss Available To Common Stockholders, Basic$-224.72 Million
    Research and Development$27.63 Million
    Preferred Stock Dividends And Other Adjustments$0

    Comprehensive Income

    December 1, 2023 to November 30, 2024
    MetricValue
    Comprehensive Income/Loss$-223.76 Million
    Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
    Comprehensive Income/Loss Attributable To Parent$-223.76 Million
    Other Comprehensive Income/Loss$171.86 Million

    Balance Sheet

    December 1, 2023 to November 30, 2024
    MetricValue
    Liabilities$104.78 Million
    Equity$186.77 Million
    Noncurrent Liabilities$16.19 Million
    Accounts Payable$34.75 Million
    Equity Attributable To Parent$186.77 Million
    Intangible Assets$73.11 Million

    Historical Dividends

    Announcement DatePayment DateRecord DateAmountFrequency
    No historical dividends

    Recent Headlines From The Web

    Latest news, press releases, and media coverage about ANGO from trusted financial sources

      Related Companies

      Additional publicly traded companies similar to AngioDynamics (ANGO)
      Boost your savings and earn 4.15% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.